Public procurement notice: Voluntary Ex Ante Transparency Notice
Published: 2023-05-17
Buyer: SYKEHUSINNKJØP HF
Country: NO
Contract type: Supplies
Procedure: Contract award without prior publication
CPV classification: 33000000 | 38000000
Estimated value: 12500000 NOK
Award criteria: The most economic tender

Technical requirements: Instruments for mass spectrometry (MALDI-TOF MS) for the Microbiological Department, Bergen Hospital Trust
Bergen Hospital Trust intends to enter into a contract with BRUKER NORDIC AB for the delivery of MALDI-TOF MS. One instrument will be procured in 2023 and there is an option for one extra instrument. A procurement contract and a framework agreement will be entered into for instrument-dependent consumables with a duration lasting as long as the instruments are in use.
The contracting authority is aware that there are two alternative instruments in the market. One delivered by bioMérieux and the other from Bruker Nordic. Both suppliers presented their instruments to the contracting authority in autumn 2022.
The instrument that will be procured must be compatible with other instruments in the section (BD Kiestra Total Lab Automation (TLA) System), and it is only the MALDI-TOF instruments from Bruker Nordic that fulfils this need.
The reason for an option being added for an extra instrument is that the section currently has two instruments that need replacing. One now in 2023. Our two instruments must be from the same supplier due to operating routines, and because the instruments must have the same database.
Based on the mentioned justifications, the Contracting Authority believes that there is a legal basis to enter into a contract for the procurement of a MALDI-TOF MS and the accompanying instrument-dependent consumables with Bruker Nordic AB without announcing a contest, cf. the Public Procurement Regulations § 21-5, c.f. § 13-4 first paragraph, letter b, point 2.
Option for an extra instrument, service at different levels, service course, multiuse plates, and extra databases.
Bergen Hospital Trust intends to enter into a contract with BRUKER NORDIC AB for the delivery of MALDI-TOF MS. One instrument will be procured in 2023 and there is an option for one extra instrument. A procurement contract and a framework agreement will be entered into for instrument-dependent consumables with a duration lasting as long as the instruments are in use.
The contracting authority is aware that there are two alternative instruments in the market. One delivered by bioMérieux and the other from Bruker Nordic. Both suppliers presented their instruments to the contracting authority in autumn 2022.
The instrument that will be procured must be compatible with other instruments in the section (BD Kiestra Total Lab Automation (TLA) System), and it is only the MALDI-TOF instruments from Bruker Nordic that fulfils this need. The reason for an option being added for an extra instrument is that the section currently has two instruments that need replacing. One now in 2023. Our two instruments must be from the same supplier due to operating routines, and because the instruments must have the same database.
Based on the mentioned justifications, the Contracting Authority believes that there is a legal basis to enter into a contract for the procurement of a MALDI-TOF MS and the accompanying instrument-dependent consumables with Bruker Nordic AB without announcing a contest, cf. the Public Procurement Regulations § 21-5, c.f. § 13-4 first paragraph, letter b, point 2.


Winner: Bruker Nordic AB
Award value: 12500000